Zydus receives marketing exclusivity approval for Sirolimus tablets – Business Standard
Business TodayZydus receives marketing exclusivity approval for Sirolimus tabletsBusiness StandardThe Ahmedabad-based Zydus Cadila received the final approval from the US FDA to market Sirolimus tablets 0.5 mg with 180 days of marketing exclusivity. As…
